Ketamine is an anesthetic that was once used mainly on the battlefield. It has emerged to be a promising treatment for treatment-resistant depression, major depression disorder, and several chronic pain conditions. Esketamine, an intranasal ketamine spray, is FDA approved for the treatment of treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions. Studies have demonstrated that a sub-anesthetic dose of ketamine can induce rapid and sustained antidepressant actions in treatment-resistant patients. Ketamine for the treatment of depression is unique as it induces rapid antidepressant effects unlike the delayed effect of currently approved anti-depression medications.
Conditions treated with ketamine therapy:
- Treatment-Resistant Depression (TRD)
- Major Depressive Disorder
- Bipolar Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Obsessive-Compulsive Disorder (OCD)
- Chronic Pain
- Complex Regional Pain Syndrome (CRPS)
- Neuropathic Pain
- Migraine Headaches
Our team of physicians is:
Medhat Guirguis MD – board certified in psychiatry and geriatric psychiatry
Ingy Iskander MD – board certified in anesthesiology and pain management
Whether you are suffering from a mood disorder or a pain condition, you will be evaluated by the appropriate board-certified physician in the field to make sure the treatment is right for you.